EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Topical amitriptyline in burning mouth syndrome: A retrospective real‐world evidence study

Ashley Lebel iD, Dylan Da Silva Vieira, Yves Boucher iD

Headache: The Journal of Head and Face Pain · 2024

DOI: 10.1111/head.14818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2024. Verfasst von Ashley Lebel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orofacial Pain, Institute of Dental Surgery, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Burning Mouth Syndrome, Amitriptyline, Analgesics, Non-Narcotic, Administration, Topical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effectiveness, tolerability, and safety of topical amitriptyline as a potential route of administration for the management of burning mouth syndrome.

Background

Burning mouth syndrome is a complex, idiopathic, and debilitating orofacial pain disorder that impairs quality of life, with a prevalence of up to 18% in menopausal women. Available drugs to alleviate its burning sensation have inconsistent and limited efficacy. Given its physicochemical properties, excellent tolerability, and ability to target peripheral pathways, topical amitriptyline seems a promising mechanistically specific analgesic drug for burning mouth syndrome.

Methods

In this retrospective cross‐sectional real‐world evidence study, patients with burning mouth syndrome who were prescribed topical amitriptyline for 8 weeks were identified. Eligibility criteria stemmed from ICHD‐3, ICOP, and consensus definitions. The primary outcome measure was mean daily pain intensity (on a 0–10 scale); secondary outcomes included adverse events and patient global impression of improvement. Data are given as the mean ± SD.

Results

A total of 15 patients fulfilling the eligibility criteria were included and analyzed. Mean daily pain was 6.7 ± 2.1 at baseline and 3.7 ± 2.3 after treatment, with a mean reduction of 3.1 ± 2.8 ( p = 0.002). Half of the patients experienced a decrease in pain by at least 50% ( p = 0.008). Several mild adverse events were reported, such as somnolence or dry mouth.

Conclusions

Topical amitriptyline may be a safe and potent route of administration in the treatment of burning mouth syndrome, a hypothesis to be tested in further controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burning Mouth SyndromeAmitriptylineAnalgesics, Non-NarcoticAdministration, TopicalHumansFemaleRetrospective StudiesMiddle AgedMaleCross-Sectional StudiesAgedAdultTreatment Outcome

Stichwörter der Autor:innen

antidepressantsburning mouth disorderelectronic medical recordsneuropathic painpaintopical analgesics

Substanzen

AmitriptylineAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Orofacial Pain, Institute of Dental Surgery, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Department of Orofacial Neurobiology (LabNOF EA7543), Orofacial Pathologies, Imaging and Biotherapies URP2496, Université Paris Cité, Montrouge, France.
  • Gene Regulation and Adaptive Behaviors, CNRS UMR8246, INSERM, Neuroscience Paris Seine, Sorbonne Université, Paris, France.

ORCID-Profile: Ashley Lebel, Yves Boucher

Zitieren

APA

Lebel, A., Da Silva Vieira, D., & Boucher, Y. (2024). Topical amitriptyline in burning mouth syndrome: A retrospective real‐world evidence study. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14818

Vancouver

Lebel A, Da Silva Vieira D, Boucher Y. Topical amitriptyline in burning mouth syndrome: A retrospective real‐world evidence study. Headache: The Journal of Head and Face Pain. 2024. doi:10.1111/head.14818

BibTeX
@article{Lebel2024,
  author = {Lebel, Ashley and Da Silva Vieira, Dylan and Boucher, Yves},
  title = {Topical amitriptyline in burning mouth syndrome: A retrospective real‐world evidence study},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  doi = {10.1111/head.14818}
}
Kostenlos starten →